共 10 条
Chemical modification of rapamycin: The discovery of SDZ RAD
被引:121
作者:

Sedrani, R
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma AG, Preclin Res, CH-4002 Basel, Switzerland Novartis Pharma AG, Preclin Res, CH-4002 Basel, Switzerland

Cottens, S
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma AG, Preclin Res, CH-4002 Basel, Switzerland Novartis Pharma AG, Preclin Res, CH-4002 Basel, Switzerland

Kallen, J
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma AG, Preclin Res, CH-4002 Basel, Switzerland Novartis Pharma AG, Preclin Res, CH-4002 Basel, Switzerland

Schuler, W
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma AG, Preclin Res, CH-4002 Basel, Switzerland Novartis Pharma AG, Preclin Res, CH-4002 Basel, Switzerland
机构:
[1] Novartis Pharma AG, Preclin Res, CH-4002 Basel, Switzerland
关键词:
D O I:
10.1016/S0041-1345(98)00587-9
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
引用
收藏
页码:2192 / 2194
页数:3
相关论文
共 10 条
[1]
A MAMMALIAN PROTEIN TARGETED BY G1-ARRESTING RAPAMYCIN-RECEPTOR COMPLEX
[J].
BROWN, EJ
;
ALBERS, MW
;
SHIN, TB
;
ICHIKAWA, K
;
KEITH, CT
;
LANE, WS
;
SCHREIBER, SL
.
NATURE,
1994, 369 (6483)
:756-758

BROWN, EJ
论文数: 0 引用数: 0
h-index: 0
机构: HARVARD UNIV,HOWARD HUGHES MED INST,DEPT CHEM,CAMBRIDGE,MA 02138

ALBERS, MW
论文数: 0 引用数: 0
h-index: 0
机构: HARVARD UNIV,HOWARD HUGHES MED INST,DEPT CHEM,CAMBRIDGE,MA 02138

SHIN, TB
论文数: 0 引用数: 0
h-index: 0
机构: HARVARD UNIV,HOWARD HUGHES MED INST,DEPT CHEM,CAMBRIDGE,MA 02138

ICHIKAWA, K
论文数: 0 引用数: 0
h-index: 0
机构: HARVARD UNIV,HOWARD HUGHES MED INST,DEPT CHEM,CAMBRIDGE,MA 02138

KEITH, CT
论文数: 0 引用数: 0
h-index: 0
机构: HARVARD UNIV,HOWARD HUGHES MED INST,DEPT CHEM,CAMBRIDGE,MA 02138

LANE, WS
论文数: 0 引用数: 0
h-index: 0
机构: HARVARD UNIV,HOWARD HUGHES MED INST,DEPT CHEM,CAMBRIDGE,MA 02138

SCHREIBER, SL
论文数: 0 引用数: 0
h-index: 0
机构: HARVARD UNIV,HOWARD HUGHES MED INST,DEPT CHEM,CAMBRIDGE,MA 02138
[2]
Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP
[J].
Choi, JW
;
Chen, J
;
Schreiber, SL
;
Clardy, J
.
SCIENCE,
1996, 273 (5272)
:239-242

Choi, JW
论文数: 0 引用数: 0
h-index: 0
机构: HARVARD UNIV,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02138

Chen, J
论文数: 0 引用数: 0
h-index: 0
机构: HARVARD UNIV,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02138

Schreiber, SL
论文数: 0 引用数: 0
h-index: 0
机构: HARVARD UNIV,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02138

Clardy, J
论文数: 0 引用数: 0
h-index: 0
机构: HARVARD UNIV,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02138
[3]
PROLONGATION OF RENAL-ALLOGRAFT SURVIVAL IN A LARGE ANIMAL-MODEL BY ORAL RAPAMYCIN MONOTHERAPY
[J].
GRANGER, DK
;
CROMWELL, JW
;
CHEN, SC
;
GOSWITZ, JJ
;
MORROW, DT
;
BEIERLE, FA
;
SEHGAL, SN
;
CANAFAX, DM
;
MATAS, AJ
.
TRANSPLANTATION,
1995, 59 (02)
:183-186

GRANGER, DK
论文数: 0 引用数: 0
h-index: 0
机构: UNIV MINNESOTA,DEPT PHARM PRACTICE,MINNEAPOLIS,MN 55455

CROMWELL, JW
论文数: 0 引用数: 0
h-index: 0
机构: UNIV MINNESOTA,DEPT PHARM PRACTICE,MINNEAPOLIS,MN 55455

CHEN, SC
论文数: 0 引用数: 0
h-index: 0
机构: UNIV MINNESOTA,DEPT PHARM PRACTICE,MINNEAPOLIS,MN 55455

GOSWITZ, JJ
论文数: 0 引用数: 0
h-index: 0
机构: UNIV MINNESOTA,DEPT PHARM PRACTICE,MINNEAPOLIS,MN 55455

MORROW, DT
论文数: 0 引用数: 0
h-index: 0
机构: UNIV MINNESOTA,DEPT PHARM PRACTICE,MINNEAPOLIS,MN 55455

BEIERLE, FA
论文数: 0 引用数: 0
h-index: 0
机构: UNIV MINNESOTA,DEPT PHARM PRACTICE,MINNEAPOLIS,MN 55455

SEHGAL, SN
论文数: 0 引用数: 0
h-index: 0
机构: UNIV MINNESOTA,DEPT PHARM PRACTICE,MINNEAPOLIS,MN 55455

CANAFAX, DM
论文数: 0 引用数: 0
h-index: 0
机构: UNIV MINNESOTA,DEPT PHARM PRACTICE,MINNEAPOLIS,MN 55455

MATAS, AJ
论文数: 0 引用数: 0
h-index: 0
机构: UNIV MINNESOTA,DEPT PHARM PRACTICE,MINNEAPOLIS,MN 55455
[4]
RAPAMYCIN INHIBITS ARTERIAL INTIMAL THICKENING CAUSED BY BOTH ALLOIMMUNE AND MECHANICAL INJURY - ITS EFFECT ON CELLULAR, GROWTH-FACTOR, AND CYTOKINE RESPONSES IN INJURED VESSELS
[J].
GREGORY, CR
;
HUIE, P
;
BILLINGHAM, ME
;
MORRIS, RE
.
TRANSPLANTATION,
1993, 55 (06)
:1409-1418

GREGORY, CR
论文数: 0 引用数: 0
h-index: 0
机构: STANFORD UNIV,MED CTR,SCH MED,DEPT CARDIOTHORAC SURG,TRANSPLANTAT IMMUNOL LAB,STANFORD,CA 94305

HUIE, P
论文数: 0 引用数: 0
h-index: 0
机构: STANFORD UNIV,MED CTR,SCH MED,DEPT CARDIOTHORAC SURG,TRANSPLANTAT IMMUNOL LAB,STANFORD,CA 94305

BILLINGHAM, ME
论文数: 0 引用数: 0
h-index: 0
机构: STANFORD UNIV,MED CTR,SCH MED,DEPT CARDIOTHORAC SURG,TRANSPLANTAT IMMUNOL LAB,STANFORD,CA 94305

MORRIS, RE
论文数: 0 引用数: 0
h-index: 0
机构: STANFORD UNIV,MED CTR,SCH MED,DEPT CARDIOTHORAC SURG,TRANSPLANTAT IMMUNOL LAB,STANFORD,CA 94305
[5]
Sirolimus: A new agent for clinical renal transplantation
[J].
Kahan, BD
.
TRANSPLANTATION PROCEEDINGS,
1997, 29 (1-2)
:48-50

Kahan, BD
论文数: 0 引用数: 0
h-index: 0
[6]
X-ray crystal structure of 28-O-methylrapamycin complexed with FKBP12: Is the cyclohexyl moiety part of the effector domain of rapamycin?
[J].
Kallen, JA
;
Sedrani, R
;
Cottens, S
.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY,
1996, 118 (25)
:5857-5861

Kallen, JA
论文数: 0 引用数: 0
h-index: 0
机构: Department of Preclinical Research, Sandoz Pharma Ltd.

Sedrani, R
论文数: 0 引用数: 0
h-index: 0
机构: Department of Preclinical Research, Sandoz Pharma Ltd.

Cottens, S
论文数: 0 引用数: 0
h-index: 0
机构: Department of Preclinical Research, Sandoz Pharma Ltd.
[7]
RAFT1 - A MAMMALIAN PROTEIN THAT BINDS TO FKBP12 IN A RAPAMYCIN-DEPENDENT FASHION AND IS HOMOLOGOUS TO YEAST TORS
[J].
SABATINI, DM
;
ERDJUMENTBROMAGE, H
;
LUI, M
;
TEMPST, P
;
SNYDER, SH
.
CELL,
1994, 78 (01)
:35-43

SABATINI, DM
论文数: 0 引用数: 0
h-index: 0
机构:
MEM SLOAN KETTERING CANC CTR, PROGRAM MOLEC BIOL, NEW YORK, NY 10021 USA MEM SLOAN KETTERING CANC CTR, PROGRAM MOLEC BIOL, NEW YORK, NY 10021 USA

ERDJUMENTBROMAGE, H
论文数: 0 引用数: 0
h-index: 0
机构:
MEM SLOAN KETTERING CANC CTR, PROGRAM MOLEC BIOL, NEW YORK, NY 10021 USA MEM SLOAN KETTERING CANC CTR, PROGRAM MOLEC BIOL, NEW YORK, NY 10021 USA

LUI, M
论文数: 0 引用数: 0
h-index: 0
机构:
MEM SLOAN KETTERING CANC CTR, PROGRAM MOLEC BIOL, NEW YORK, NY 10021 USA MEM SLOAN KETTERING CANC CTR, PROGRAM MOLEC BIOL, NEW YORK, NY 10021 USA

TEMPST, P
论文数: 0 引用数: 0
h-index: 0
机构:
MEM SLOAN KETTERING CANC CTR, PROGRAM MOLEC BIOL, NEW YORK, NY 10021 USA MEM SLOAN KETTERING CANC CTR, PROGRAM MOLEC BIOL, NEW YORK, NY 10021 USA

SNYDER, SH
论文数: 0 引用数: 0
h-index: 0
机构:
MEM SLOAN KETTERING CANC CTR, PROGRAM MOLEC BIOL, NEW YORK, NY 10021 USA MEM SLOAN KETTERING CANC CTR, PROGRAM MOLEC BIOL, NEW YORK, NY 10021 USA
[8]
ISOLATION OF A PROTEIN TARGET OF THE FKBP12-RAPAMYCIN COMPLEX IN MAMMALIAN-CELLS
[J].
SABERS, CJ
;
MARTIN, MM
;
BRUNN, GJ
;
WILLIAMS, JM
;
DUMONT, FJ
;
WIEDERRECHT, G
;
ABRAHAM, RT
.
JOURNAL OF BIOLOGICAL CHEMISTRY,
1995, 270 (02)
:815-822

SABERS, CJ
论文数: 0 引用数: 0
h-index: 0
机构: MAYO CLIN & MAYO FDN,DEPT IMMUNOL,ROCHESTER,MN 55905

MARTIN, MM
论文数: 0 引用数: 0
h-index: 0
机构: MAYO CLIN & MAYO FDN,DEPT IMMUNOL,ROCHESTER,MN 55905

BRUNN, GJ
论文数: 0 引用数: 0
h-index: 0
机构: MAYO CLIN & MAYO FDN,DEPT IMMUNOL,ROCHESTER,MN 55905

WILLIAMS, JM
论文数: 0 引用数: 0
h-index: 0
机构: MAYO CLIN & MAYO FDN,DEPT IMMUNOL,ROCHESTER,MN 55905

DUMONT, FJ
论文数: 0 引用数: 0
h-index: 0
机构: MAYO CLIN & MAYO FDN,DEPT IMMUNOL,ROCHESTER,MN 55905

WIEDERRECHT, G
论文数: 0 引用数: 0
h-index: 0
机构: MAYO CLIN & MAYO FDN,DEPT IMMUNOL,ROCHESTER,MN 55905

ABRAHAM, RT
论文数: 0 引用数: 0
h-index: 0
机构: MAYO CLIN & MAYO FDN,DEPT IMMUNOL,ROCHESTER,MN 55905
[9]
SDZ RAD, a new rapamycin derivative - Pharmacological properties in vitro and in vivo
[J].
Schuler, W
;
Sedrani, R
;
Cottens, S
;
Haberlin, B
;
Schulz, M
;
Schuurman, HJ
;
Zenke, G
;
Zerwes, HG
;
Schreier, MH
.
TRANSPLANTATION,
1997, 64 (01)
:36-42

Schuler, W
论文数: 0 引用数: 0
h-index: 0
机构:
NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND

Sedrani, R
论文数: 0 引用数: 0
h-index: 0
机构:
NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND

Cottens, S
论文数: 0 引用数: 0
h-index: 0
机构:
NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND

Haberlin, B
论文数: 0 引用数: 0
h-index: 0
机构:
NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND

Schulz, M
论文数: 0 引用数: 0
h-index: 0
机构:
NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND

Schuurman, HJ
论文数: 0 引用数: 0
h-index: 0
机构:
NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND

Zenke, G
论文数: 0 引用数: 0
h-index: 0
机构:
NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND

Zerwes, HG
论文数: 0 引用数: 0
h-index: 0
机构:
NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND

Schreier, MH
论文数: 0 引用数: 0
h-index: 0
机构:
NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND NOVARTIS PHARMA AG, TECH RES & DEV, CH-4002 BASEL, SWITZERLAND
[10]
SDZ RAD, a new rapamycin derivative - Synergism with cyclosporine
[J].
Schuurman, HJ
;
Cottens, S
;
Fuchs, S
;
Joergensen, J
;
Meerloo, T
;
Sedrani, R
;
Tanner, M
;
Zenke, G
;
Schuler, W
.
TRANSPLANTATION,
1997, 64 (01)
:32-35

Schuurman, HJ
论文数: 0 引用数: 0
h-index: 0
机构: Preclinical Research Transplantation, Building 386/101B, Novartis Pharma Inc.

Cottens, S
论文数: 0 引用数: 0
h-index: 0
机构: Preclinical Research Transplantation, Building 386/101B, Novartis Pharma Inc.

Fuchs, S
论文数: 0 引用数: 0
h-index: 0
机构: Preclinical Research Transplantation, Building 386/101B, Novartis Pharma Inc.

Joergensen, J
论文数: 0 引用数: 0
h-index: 0
机构: Preclinical Research Transplantation, Building 386/101B, Novartis Pharma Inc.

Meerloo, T
论文数: 0 引用数: 0
h-index: 0
机构: Preclinical Research Transplantation, Building 386/101B, Novartis Pharma Inc.

Sedrani, R
论文数: 0 引用数: 0
h-index: 0
机构: Preclinical Research Transplantation, Building 386/101B, Novartis Pharma Inc.

Tanner, M
论文数: 0 引用数: 0
h-index: 0
机构: Preclinical Research Transplantation, Building 386/101B, Novartis Pharma Inc.

Zenke, G
论文数: 0 引用数: 0
h-index: 0
机构: Preclinical Research Transplantation, Building 386/101B, Novartis Pharma Inc.

Schuler, W
论文数: 0 引用数: 0
h-index: 0
机构: Preclinical Research Transplantation, Building 386/101B, Novartis Pharma Inc.